Blended Survival Curves: A New Approach to Extrapolation for Time-to-Event Outcomes from Clinical Trials in Health Technology Assessment
Author
Abstract
Suggested Citation
DOI: 10.1177/0272989X221134545
Download full text from publisher
References listed on IDEAS
- Helen Bell Gorrod & Ben Kearns & John Stevens & Praveen Thokala & Alexander Labeit & Nicholas Latimer & David Tyas & Ahmed Sowdani, 2019. "A Review of Survival Analysis Methods Used in NICE Technology Appraisals of Cancer Treatments: Consistency, Limitations, and Areas for Improvement," Medical Decision Making, , vol. 39(8), pages 899-909, November.
- Christopher Jackson & John Stevens & Shijie Ren & Nick Latimer & Laura Bojke & Andrea Manca & Linda Sharples, 2017. "Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods," Medical Decision Making, , vol. 37(4), pages 377-390, May.
- James Larkin & Anthony J Hatswell & Paul Nathan & Maximilian Lebmeier & Dawn Lee, 2015. "The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK," PLOS ONE, Public Library of Science, vol. 10(12), pages 1-11, December.
- Patricia Guyot & Anthony E. Ades & Matthew Beasley & Béranger Lueza & Jean-Pierre Pignon & Nicky J. Welton, 2017. "Extrapolation of Survival Curves from Cancer Trials Using External Information," Medical Decision Making, , vol. 37(4), pages 353-366, May.
- Adrian Vickers, 2019. "An Evaluation of Survival Curve Extrapolation Techniques Using Long-Term Observational Cancer Data," Medical Decision Making, , vol. 39(8), pages 926-938, November.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Ash Bullement & Matthew D. Stevenson & Gianluca Baio & Gemma E. Shields & Nicholas R. Latimer, 2023. "A Systematic Review of Methods to Incorporate External Evidence into Trial-Based Survival Extrapolations for Health Technology Assessment," Medical Decision Making, , vol. 43(5), pages 610-620, July.
- Daniel Gallacher & Peter Kimani & Nigel Stallard, 2022. "Biased Survival Predictions When Appraising Health Technologies in Heterogeneous Populations," PharmacoEconomics, Springer, vol. 40(1), pages 109-120, January.
- M. A. Chaudhary & M. Edmondson-Jones & G. Baio & E. Mackay & J. R. Penrod & D. J. Sharpe & G. Yates & S. Rafiq & K. Johannesen & M. K. Siddiqui & J. Vanderpuye-Orgle & A. Briggs, 2023. "Use of Advanced Flexible Modeling Approaches for Survival Extrapolation from Early Follow-up Data in two Nivolumab Trials in Advanced NSCLC with Extended Follow-up," Medical Decision Making, , vol. 43(1), pages 91-109, January.
- M. Campioni & I. Agirrezabal & R. Hajek & J. Minarik & L. Pour & I. Spicka & S. Gonzalez-McQuire & P. Jandova & V. Maisnar, 2020. "Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(2), pages 219-233, March.
- Nicholas R. Latimer & Kurt Taylor & Anthony J. Hatswell & Sophia Ho & Gabriel Okorogheye & Clara Chen & Inkyu Kim & John Borrill & David Bertwistle, 2024. "An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?," PharmacoEconomics, Springer, vol. 42(12), pages 1395-1412, December.
- Daniel Gallacher & Peter Kimani & Nigel Stallard, 2021. "Extrapolating Parametric Survival Models in Health Technology Assessment: A Simulation Study," Medical Decision Making, , vol. 41(1), pages 37-50, January.
- Taihang Shao & Mingye Zhao & Leyi Liang & Lizheng Shi & Wenxi Tang, 2023. "Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067," PharmacoEconomics - Open, Springer, vol. 7(3), pages 383-392, May.
- Fuhmei Wang & Jung-Der Wang & Yu-Wen Hung, 2018. "Universal health insurance, health inequality and oral cancer in Taiwan," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-13, October.
- Adrian Vickers, 2019. "An Evaluation of Survival Curve Extrapolation Techniques Using Long-Term Observational Cancer Data," Medical Decision Making, , vol. 39(8), pages 926-938, November.
- Alexina J. Mason & Manuel Gomes & James Carpenter & Richard Grieve, 2021. "Flexible Bayesian longitudinal models for cost‐effectiveness analyses with informative missing data," Health Economics, John Wiley & Sons, Ltd., vol. 30(12), pages 3138-3158, December.
- Jonathan Dando & Maximilian Lebmeier, 2020. "A novel valuation model for medical intervention development based on progressive dynamic changes that integrates Health Technology Assessment outcomes with early-stage innovation and indication-speci," Journal of Innovation and Entrepreneurship, Springer, vol. 9(1), pages 1-28, December.
- Philip Cooney & Arthur White, 2023. "Direct Incorporation of Expert Opinion into Parametric Survival Models to Inform Survival Extrapolation," Medical Decision Making, , vol. 43(3), pages 325-336, April.
- Nicholas R. Latimer & Mark J. Rutherford, 2024. "Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to Know," PharmacoEconomics, Springer, vol. 42(10), pages 1073-1090, October.
- Jing-Shiang Hwang & Tsuey-Hwa Hu, 2020. "Later-Life Exposure to Moderate PM 2.5 Air Pollution and Life Loss of Older Adults in Taiwan," IJERPH, MDPI, vol. 17(6), pages 1-12, March.
- Mathyn Vervaart & Eline Aas & Karl P. Claxton & Mark Strong & Nicky J. Welton & Torbjørn Wisløff & Anna Heath, 2023. "General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations," Medical Decision Making, , vol. 43(5), pages 595-609, July.
- Ash Bullement & Mark Edmondson-Jones & Patricia Guyot & Nicky J. Welton & Gianluca Baio & Matthew Stevenson & Nicholas R. Latimer, 2024. "MPES-R: Multi-Parameter Evidence Synthesis in R for Survival Extrapolation—A Tutorial," PharmacoEconomics, Springer, vol. 42(12), pages 1317-1327, December.
- Yang Meng & Nadine Hertel & John Ellis & Edith Morais & Helen Johnson & Zoe Philips & Neil Roskell & Andrew Walker & Dawn Lee, 2018. "The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(8), pages 1163-1172, November.
More about this item
Keywords
expert opinion; extrapolation; real world evidence; survival modeling in HTA;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:43:y:2023:i:3:p:299-310. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.